Healthcare Triangle Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
1analyst covering
FY EPS (est.)
-$16.13next fiscal year
Monitoring Framework
Key Performance Indicators
Total Consolidated Revenue Quarterly9.9M
Customer Engagement Services Segment Revenue Quarterly6.9M
Consolidated Gross Margin Quarterly24.0%
Watch Items
- Integration and performance of Teyame 360 S.L. and Datono Mediacion S.L. acquisitionsTrigger: Failure to meet the projected $34M in annual revenue and $4.2M in EBITDA from the Spanish assetsAction: Re-evaluate the valuation of intangible assets and goodwill, and adjust the contingent earnout-based equity consideration.
- Operating cash burn and reliance on external financingTrigger: Operating cash outflow exceeding available cash reserves ($4.32M as of March 31, 2026) without new financingAction: Accelerate cost optimization plans, restrict discretionary capital expenditures, or draw down on the $50M Hudson Global Ventures equity line.
- Dilution risk from convertible debt and equity line of credit (ELOC)Trigger: Conversion of the 15% OID senior convertible promissory notes or significant drawdowns on the $50M ELOCAction: Monitor outstanding share count and EPS impact; manage the timing of equity drawdowns to minimize shareholder dilution.
Research as of 20 Jun 2026